Clinical Infectious Diseases (@CIDJournal) header
Clinical Infectious Diseases (@CIDJournal) profile picture

The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @IDSAinfo

Joined February 2022
Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)
Transplant Infectious Disease Physician Workforce: A National Survey of Practice Structure, Compensation, and Job Satisfaction ✅ Just Accepted ⭐ Editor's Choice 🔗 bit.ly/4zp5ec9
1
357
Practice Structures and Compensation for Transplant Infectious Diseases: A First Step to Charting the Future of the Field ✅ Just Accepted 🔗 bit.ly/4C0J8PX
2
5
693
Interpreting Albumin-Carbapenem Effect Modification: Functional Form, Time Zero, and Local Overlap 🔁 Repost 🔗 bit.ly/3U3AbV0
1
6
921
Antibiotic Stewardship, Resistance, and Mortality in Vancomycin-Resistant Enterococcus: A Quasi-Experimental Study of Linezolid Restrictions 🔁 Repost ⭐ Editor's Choice 🔗 bit.ly/4BcHhqZ
4
7
961
The piperacillin-tazobactam is behaving like a prognostic factor, but that does not negate the pharmacodynamic hypothesis 🔁 Repost 🔗 bit.ly/3VXonUL
3
17
1,665
Hypoalbuminemia and Pharmacokinetics: Revisiting Fundamental Principles and Clinical Perspectives 🔁 Repost 🔗 bit.ly/47BCXUx
4
7
1,436
Cefepime–Zidebactam for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria, Including Metallo-β-Lactamase Producers: A Phase 2, Open-Label, Single-Arm, Multicenter Study 🔁 Repost ⭐ Editor's Choice 🔗 bit.ly/47KCJKQ
2
11
1,257
Ertapenem in Hypoalbuminemia: Methodological and Pharmacokinetic Considerations 🔁 Repost 🔗 bit.ly/4zQVjNh
1
8
24
2,501
The Piperacillin-Tazobactam MIC Behaves Like a Prognostic Marker, Not a Pharmacodynamic Exposure 🔁 Repost 🔗 bit.ly/4zKnrSg
1
6
26
1,931
Searching for the Optimal Treatment of Infections due to Non-Carbapenemase-Producing Carbapenem-resistant Enterobacterales ✅ Just Accepted 🔗 bit.ly/4z9fHse
16
36
2,364
Are Higher-Order Carbapenems Effective Therapy for Patients with Ertapenem-Resistant Enterobacterales Invasive Infections? ✅ Just Accepted 🔗 bit.ly/4BOQ3LO
6
33
1,730
Myths and Misconceptions About Modern Antiretroviral Therapy for HIV Treatment ✅ Just Accepted 🔗 bit.ly/4k2TLvc
1
4
11
836
Special populations require special research approaches ✅ Just Accepted 🔗 bit.ly/4elnUCa
1
1
3
843
Relationships between Schistosoma mansoni infection intensity, environmental enteric dysfunction (EED), and anemia type among preschool-aged children in Uganda ✅ Just Accepted 🔗 bit.ly/4j06H3L
1
5
767
Considerations for Assessing Measles Healthcare Facility Exposures ✅ Just Accepted 🔗 bit.ly/47XLe5u
1
4
748
Refining Measles Contact Tracing Without Diluting Protection for High-Risk Children ✅ Just Accepted 🔗 bit.ly/4zocq9l
3
697
Acute Chagas disease from probable oral ingestion of Trypanosoma cruzi in the United States – high risk for severe disease ✅ Just Accepted 🔗 bit.ly/3UZ1W1j
1
4
12
972